Message from Jessica Hill – Canadian Partnership Against Cancer
To make meaningful progress in cancer control, the work being done must be anchored in the experiences of cancer patients and survivors. As the Canadian Partnership Against Cancer implements Canada’s cancer control strategy – a strategy informed by the realities and challenges facing people treated through and working in the cancer system – we draw on CCAN and the collective experience of its member organizations to tap into this important perspective.
Working together with patients and survivors, we are taking a focused approach that will help prevent cancer, enhance the quality of life of those affected by cancer, lessen the likelihood of dying from cancer, and increase the efficiency of cancer control in Canada.
The Partnership is proud to contribute to CCAN’s projects and initiatives to ensure the patient and survivor voice is reflected in cancer control. We thank you, the many patients and survivors who have shared your voice and passion, as we work together to implement the pan-Canadian cancer control strategy.
Jessica Hill, CEO
For more information, please visit: Canadian Partnership Against Cancer.
Canadian Partnership Against Cancer Advisory Groups
In order to advance their work, the Canadian Partnership Against Cancer welcomes the voice of cancer patients and survivors to each of the Advisory Groups. Patient representatives provide a valuable perspective to the work of each group while reporting back to CCAN Members Council on the accomplishments, initiatives and strategies of each of the following groups:
Cancer Guidelines Advisory Group
CCAN Representative: Diana Ermel
Guidelines are statements, based on evidence, that steer clinical practice and policy decisions. High-quality guidelines are powerful tools that promote appropriate practice, inform investment in new technologies and enhance quality improvement programs. In patient care, for example, guidelines provide a basis for quality, consistent care developed from the best available knowledge.
Screening Advisory Group
CCAN Member: Diane Spencer
Catching cancers early can have significant impact on treatment and survival. With effective tests available for the early detection of breast, cervical and colorectal cancer, championing the use of screening in these areas is vital. The Partnership supports organized delivery of screening through population-based programs, which offer high-quality tests to everyone in a demographic group. Screening programs will be supported through the development of performance indicators, the sharing of effective strategies to improve access and participation, and fostering collaborative work across jurisdictions.
Cancer Journey Advisory Group
CCAN Representative: Liz Whamond
A cancer diagnosis brings emotional, social, spiritual and practical consequences for patients and families that can reach well beyond the time spent in treatment.
For many people, lack of access to information and supportive care services makes the cancer experience much more difficult. There is also growing evidence that survivors may continue to have special needs after their cancer has been treated. For others, improvements are needed in end-of-life care.
The Cancer Journey Advisory Group strives to provide and foster leadership to promote integrated, person-centred care throughout the cancer journey.
Research Advisory Group
CCAN Representative: Jack Shapiro
The Canadian Cancer Research Alliance (CCRA) came together at the same time as the Canadian Strategy for Cancer Control. The 24-member organization brings together most of the major national funders of cancer research in Canada. This group has become the Research Action Group for the Partnership.
Primary Prevention Advisory Group
CCAN Member: Archie McCulloch
The Primary Prevention Advisory Group is a network of experts from across the cancer control community. Its role is to help reduce the rates of preventable cancers in Canada. This will reduce illness and death from cancer. It offers a leadership role in promoting major change in the cancer control and health care communities. The Action Group’s membership includes Canadian experts in research, data gathering and analysis (surveillance) and prevention programs as well as patient and survivor representatives.
Surveillance Advisory Group
CCAN Representative: Herold Driedger
Surveillance is the collection and analysis of data to monitor changes in cancer patterns, such as the number of new cases, prevalence and survival rates. Establishing a coordinated cancer surveillance system, including connecting the many areas where information resides, will facilitate comparisons and enable accurate conclusions.
ADVISORY GROUP DESCRIPTIONS provided by the Canadian Partnership Against Cancer.